Literature DB >> 29186718

Interferon-Stimulated Genes as Enhancers of Antiviral Innate Immune Signaling.

Keaton M Crosse1, Ebony A Monson, Michael R Beard, Karla J Helbig.   

Abstract

The ability of a host to curb a viral infection is heavily reliant on the effectiveness of an initial antiviral innate immune response, resulting in the upregulation of interferon (IFN) and, subsequently, IFN-stimulated genes (ISGs). ISGs serve to mount an antiviral state within a host cell, and although the specific antiviral function of a number of ISGs has been characterized, the function of many of these ISGs remains to be determined. Recent research has uncovered a novel role for a handful of ISGs, some of them directly induced by IFN regulatory factor 3 in the absence of IFN itself. These ISGs, most with potent antiviral activity, are also able to augment varying arms of the innate immune response to viral infection, thereby strengthening this response. This new understanding of the role of ISGs may, in turn, help the recent advancement of novel therapeutics aiming to augment innate signaling pathways in an attempt to control viral infection and pathogenesis.
© 2017 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Innate immunity; Interferon; Interferon-stimulated genes; Virus

Mesh:

Substances:

Year:  2017        PMID: 29186718      PMCID: PMC5969054          DOI: 10.1159/000484258

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  50 in total

1.  TRAF family proteins link PKR with NF-kappa B activation.

Authors:  Jesús Gil; Maria Angel García; Paulino Gomez-Puertas; Susana Guerra; Joaquín Rullas; Hiroyasu Nakano; José Alcamí; Mariano Esteban
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

2.  DDX60, a DEXD/H box helicase, is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling.

Authors:  Moeko Miyashita; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

3.  ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses.

Authors:  Sumio Hayakawa; Souichi Shiratori; Hiroaki Yamato; Takeshi Kameyama; Chihiro Kitatsuji; Fumi Kashigi; Showhey Goto; Shoichiro Kameoka; Daisuke Fujikura; Taisho Yamada; Tatsuaki Mizutani; Mika Kazumata; Maiko Sato; Junji Tanaka; Masahiro Asaka; Yusuke Ohba; Tadaaki Miyazaki; Masahiro Imamura; Akinori Takaoka
Journal:  Nat Immunol       Date:  2010-11-21       Impact factor: 25.606

4.  IRF3 and IRF7 phosphorylation in virus-infected cells does not require double-stranded RNA-dependent protein kinase R or Ikappa B kinase but is blocked by Vaccinia virus E3L protein.

Authors:  E J Smith; I Marié; A Prakash; A García-Sastre; D E Levy
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

5.  Autophosphorylation of the protein kinase dependent on double-stranded RNA.

Authors:  J Galabru; A Hovanessian
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

6.  ZAP-mediated mRNA degradation.

Authors:  Yiping Zhu; Guangxia Gao
Journal:  RNA Biol       Date:  2008-04-03       Impact factor: 4.652

Review 7.  TRIM/RBCC, a novel class of 'single protein RING finger' E3 ubiquitin ligases.

Authors:  Germana Meroni; Graciana Diez-Roux
Journal:  Bioessays       Date:  2005-11       Impact factor: 4.345

8.  Human TRIM gene expression in response to interferons.

Authors:  Laetitia Carthagena; Anna Bergamaschi; Joseph M Luna; Annie David; Pradeep D Uchil; Florence Margottin-Goguet; Walther Mothes; Uriel Hazan; Catherine Transy; Gianfranco Pancino; Sébastien Nisole
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

Review 9.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

10.  TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus.

Authors:  Ruth E Watkinson; William A McEwan; Jerry C H Tam; Marina Vaysburd; Leo C James
Journal:  PLoS Pathog       Date:  2015-10-27       Impact factor: 6.823

View more
  40 in total

1.  An alternative model for type I interferon induction downstream of human TLR2.

Authors:  Timo Oosenbrug; Michel J van de Graaff; Mariëlle C Haks; Sander van Kasteren; Maaike E Ressing
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

2.  Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients.

Authors:  Yuki Togami; Hisatake Matsumoto; Jumpei Yoshimura; Tsunehiro Matsubara; Takeshi Ebihara; Hiroshi Matsuura; Yumi Mitsuyama; Takashi Kojima; Masakazu Ishikawa; Fuminori Sugihara; Haruhiko Hirata; Daisuke Okuzaki; Hiroshi Ogura
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-13       Impact factor: 10.183

Review 3.  Viperin: An ancient radical SAM enzyme finds its place in modern cellular metabolism and innate immunity.

Authors:  Soumi Ghosh; E Neil G Marsh
Journal:  J Biol Chem       Date:  2020-06-16       Impact factor: 5.157

Review 4.  The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.

Authors:  Nicholas A Wong; Milton H Saier
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

Review 5.  Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.

Authors:  Stefania Scala; Roberto Pacelli
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

Review 6.  Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.

Authors:  Valentino Clemente; Padraig D'Arcy; Martina Bazzaro
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 7.  Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections.

Authors:  Patricio L Acosta; Alana B Byrne; Diego R Hijano; Laura B Talarico
Journal:  J Immunol Res       Date:  2020-05-08       Impact factor: 4.818

8.  Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.

Authors:  Yung-Ju Yeh; Ching-Ping Tseng; Sheng-Da Hsu; His-Yuan Huang; Michael M C Lai; Hsien-Da Huang; Ju-Chien Cheng
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

9.  Role of Pegylated Interferon in Patients with Chronic Liver Diseases in the Context of SARS-CoV-2 Infection.

Authors:  Sheikh Mf Akbar; Mamun A Mahtab; Julio C Aguilar; Md H Uddin; Md Sakirul I Khan; Osamu Yoshida; Eduardo Penton; Guillen N Gerardo; Yoichi Hiasa
Journal:  Euroasian J Hepatogastroenterol       Date:  2021 Jan-Jun

10.  Analysis of Global Transcriptome Change in Mouse Embryonic Fibroblasts After dsDNA and dsRNA Viral Mimic Stimulation.

Authors:  Xin Xie; Pu-Ste Liu; Piergiorgio Percipalle
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.